Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 3/20 | 0.45 |
| ▸ | CHRNB4 | P30926 | 3/20 | 0.45 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.45 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.45 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.45 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.35 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.34 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.34 |
| ▸ | EPAS1 | Q99814 | 5/20 | 0.32 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CDC25A | P30304 | 2/20 | 0.31 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.30 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Warburganal SCHEMBL288951 | 1.00 | CHRNB2 (0.45) | CHRNB2CHRNB4CHRNA3CHRNA4TRPA1 | |
| Warburganal SCHEMBL13855683 | 1.00 | CHRNB2 (0.45) | CHRNB2CHRNB4CHRNA3CHRNA4TRPA1 | |
| SCHEMBL11130748 | 0.84 | PDE4D (0.45) | CHRNB2CHRNB4CHRNA3CHRNA4TRPA1 | |
| Mukaadial SCHEMBL20462894 | 0.73 | EDNRB (0.34) | CHRNB2CHRNB4CHRNA3CHRNA4TRPA1 | |
| Mukaadial SCHEMBL21025699 | 0.73 | EDNRB (0.34) | CHRNB2CHRNB4CHRNA3CHRNA4TRPA1 | |
| Cinnamodial SCHEMBL15557354 | 0.68 | EDNRB (0.41) | TRPM2PLA2G2AEPAS1MAPT | |
| Cinnamodial SCHEMBL20462860 | 0.68 | EDNRB (0.41) | TRPM2PLA2G2AEPAS1MAPT | |
| SCHEMBL28263671 | 0.62 | CHRNB2 (0.64) | CHRNB2CHRNB4CHRNA3CHRNA4TRPA1 | |
| SCHEMBL29751910 | 0.62 | CHRNB2 (0.64) | CHRNB2CHRNB4CHRNA3CHRNA4TRPA1 | |
| Polygodial SCHEMBL258239 | 0.62 | CHRNB2 (1.00) | CHRNB2CHRNB4CHRNA3CHRNA4TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4683527-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2026-01-28 | — | — | EP | disclosed |
| US-12497381-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-12-16 | — | — | US | disclosed |
| US-12478091-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-11-25 | — | — | US | disclosed |
| US-20250289796-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2025-09-18 | — | — | US | disclosed |
| US-12358888-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-07-15 | — | — | US | disclosed |
| US-12358889-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-07-15 | — | — | US | disclosed |
| CN-119950500-A | Tobacco pest-reducing and pain-relieving products and methods thereof | 瑞迪美天然有限公司 | 2025-05-09 | — | — | CN | disclosed |
| WO-2025096261-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2025-05-08 | — | — | WO | disclosed |
| CN-119908508-A | Gasified alkaloid composition and method of use thereof | 瑞迪美天然有限公司 | 2025-05-02 | — | — | CN | disclosed |
| WO-2025058941-A1 | TOBACCO HARM REDUCTION AND PAIN RELIEF PRODUCTS AND METHODS THEREOF | Ready Mix Naturals, LLC (US) | 2025-03-20 | — | — | WO | disclosed |
| US-9693971-B2 | Compositions for alleviating gastrointestinal tract disorders or associated systemic disorders in ruminants and camelids | FREIE UNIVERSITÄT BERLIN (DE) | 2017-07-04 | — | — | US | disclosed |
| EP-2879662-B1 | COMPOSITION FOR ALLEVIATING GASTROINTESTINAL DEFECTS OR SYSTEMIC SYMPTOMES ASSOCIATED HEREWITH IN RUMINANTS AND CAMELIDS | FREIE UNIVERSITÄT BERLIN (DE) | 2017-02-08 | — | — | EP | disclosed |
| US-20160199318-A1 | Anti-Viral Compound and Composition | FOREST HERBS RESEARCH LIMITED (NZ) | 2016-07-14 | — | — | US | disclosed |
| US-20160199318-A1 | Anti-Viral Compound and Composition | FOREST HERBS RESEARCH LIMITED (NZ) | 2016-07-14 | — | — | US | disclosed |
| US-20150164822-A1 | COMPOSITIONS FOR ALLEVIATING GASTROINTESTINAL TRACT DISORDERS OR ASSOCIATED SYSTEMIC DISORDERS IN RUMINANTS AND CAMELIDS | PERFORMANAT GMBH (DE) | 2015-06-18 | — | — | US | disclosed |
| EP-2879662-A1 | COMPOSITIONS FOR ALLEVIATING GASTROINTESTINAL TRACT DISORDERS OR ASSOCIATED SYSTEMIC DISORDERS IN RUMINANTS AND CAMELIDS | Freie Universität Berlin (DE) | 2015-06-10 | — | — | EP | disclosed |
| WO-2014020067-A1 | COMPOSITIONS FOR ALLEVIATING GASTROINTESTINAL TRACT DISORDERS OR ASSOCIATED SYSTEMIC DISORDERS IN RUMINANTS AND CAMELIDS | FREIE UNIVERSITÄT BERLIN (DE) | 2014-02-06 | — | — | WO | disclosed |
| WO-2013180879-A1 | CRYSTALLIZATION OF (20R) AND (20S) ANALOGS OF 2-METHYLENE-19-NOR-22-DIMETHYL-1ALPHA,25-DIHYDROXYVITAMIN D3 | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2013-12-05 | — | — | WO | disclosed |
| US-20090182057-A1 | DEUTERATED AMINOGLYCIDAL COMPOUNDS | AUSPEX PHARMACEUTICALS, INC. (US) | 2009-07-16 | — | — | US | disclosed |
| WO-2009065239-A1 | COMPOSITIONS AND THEIR USE | GIVAUDAN SA (CH) | 2009-05-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090182057-A1 | DEUTERATED AMINOGLYCIDAL COMPOUNDS | ADRB2, GLRB, ADRB1 | CHRNB2 235/4885CHRNB4 370/4885CHRNA3 242/4885 |
| US-20160199318-A1 | Anti-Viral Compound and Composition | MAVS, PML, RPL35 | CHRNB2 4885/4885CHRNB4 4882/4885CHRNA3 4851/4885 |
| US-20250289796-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | OR10J3, TRPA1, TAS2R3 | CHRNB2 389/4885CHRNB4 205/4885CHRNA3 173/4885 |
| US-12358888-B2 | Vaporizable alkaloid compositions and methods of use thereof | SRM, SCLY, SMOX | CHRNB2 98/4885CHRNB4 55/4885CHRNA3 116/4885 |
| US-12358889-B2 | Vaporizable alkaloid compositions and methods of use thereof | SRM, SCLY, SMOX | CHRNB2 98/4885CHRNB4 55/4885CHRNA3 116/4885 |
| US-12497381-B2 | Vaporizable alkaloid compositions and methods of use thereof | CHRM5, NNMT, CHRM1 | CHRNB2 82/4885CHRNB4 35/4885CHRNA3 51/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.